Introduction
Antisense oligonucleotides (ODNs) offer an interesting potential as effective therapeutic agents. By virtue of their ability to hybridize to complementary mRNA, antisense ODNs can induce its effective degradation, thereby impeding the de novo biosynthesis of target proteins.
Antisense sequence, stability, and cellular uptake, among others, determine the antisense efficiency. In vitro, the uptake properties of antisense ODNs have been well characterized. When added to cultured cells, free antisense ODNs are endocytosed but remain often largely trapped in the endocytic compartments. Their translocation from endosomal compartments is therefore essential, which can be promoted by ODN complexation with cationic lipids. The latter facilitate transfer of ODNs across the endosomal membrane, and via transport through the cytosol, ODNs passively accumulate into the nuclei. Here they acquire access to target mRNAs via interaction with the nuclear matrix, leading to an inhibition of the synthesis of target proteins (1, 2) . Not only do cationic liposomes greatly enhance the antisense effect by promoting endocytic escape of ODNs in vitro (3, 4) , they are also used to prolong the plasma half-lives of oligonucleotides in vivo (5, 6) .
The rapid development of in vivo models and pharmacokinetic distribution studies suggest that oligonucleotide delivery displays a wide spectrum of tissue distribution, ODNs being taken up in particular by organs of the reticuloendothelial system (RES) such as liver, spleen, kidney and lungs. However, brain tissue has proven to be essentially inaccessible for ODNs, following systemic administration. Accordingly, brain is a particularly challenging organ for drug targeting, also in light of the increasing number of neurodegenerative diseases that have become apparent in recent years. Moreover, unlike the success of treatments of a variety of tumors, relatively little progress has been made in the treatment of brain tumors over the last decade. Although ODNs hardly cross the blood brain barrier, they readily accumulate in neuronal tissue when injected directly into brain (7) . Furthermore, it has also been claimed that oligonucleotides, complexes with liposomes that were conjugated with transferrin receptor antibodies, OX-26, could cross the blood brain barrier and distribute over a wide area in the brain (8, 9) , although data on intracellular ODN uptake have not been reported in these studies. It has been shown that following a bolus injection of FITC-oligonucleotides into intracerebro-ventricles, the FITC signal is primarily localized to the ventricle, while continuous infusion of FITC-oligonucleotides into the ventricle causes a wide distribution in the brain, except in the white matter (10) .
However, little insight is available as to how ODNs enter cells in the brain, and whether delivery vectors will facilitate oligonucleotides in penetrating the extracellular matrix or plasma membranes, as observed in vitro.
Hence, based upon previous work on in vitro delivery of ODNs into neuronal cells, we examined here whether and how ODNs could acquire access to brain cells, using an ex vivo model involving brain slices. The data were verified by investigating directly the fate of a bolus injection in the brain in vivo. In contrast to the in vitro findings, we observed that ODNs were taken up through the whole slice without the need of carriers. We demonstrate that facilitated diffusion of ODNs through a brain cell localized nucleic acid channel can account for the high uptake of ODNs in brain slices. In comparison, a GFP-reporter plasmid did not acquire access via the channel, but rather, required cationic liposomes for cellular entry and subsequent expression. Similar properties of ODN uptake characteristics, as observed in brain slices, were apparent in vivo, following a bolus injection of ODNs in rat brain.
Material and Methods

Materials
The cationic lipid N-methyl-4(dioleyl)methylpyridiniumchloride (SAINT-2) was synthesized as described in detail elsewhere (11) . Dioleoylphosphatidylethanolamine (DOPE) was purchased All chemicals were from Sigma (Missoursi, USA), unless stated otherwise. Preparation of brain slices.
8-day-old Sprague-Dawley rat pups were decapitated and the brains were aseptically removed.
The cerebellum was dissected in ice-cold preparation medium (MEM containing 2 mM glutamax I, pH 7.3) and the meninges were carefully removed. Sagittal slices of 400µm were cut using a
McIllwain tissue chopper, separated with fine forceps and transferred onto humidified transparent membranes (Millicell-CM, Millipore). They were cultured on a liquid layer of MEM containing HBSS (25%), horse serum (25%), glutamax I (2mM) and NaHCO3 (5mM), HEPES (10mM), pH7.3, in a humidified atmosphere with 5% CO 2 at 37°C. Cultures were maintained for up to 12 days in vitro (DIV). Medium was changed every 2-3 days.
Uptake of ODNs and plasmids, and the transfection of pGFP in brain slices.
One nano mole ODN or 5 µg pGFP in 50µl DMEM were added on top of the mounted brain slices for the indicated time. Then the brain slices were washed and supplemented with fresh medium. Alternatively, the same amount of ODNs or pGFP was mixed with 75 nmol (+/-charge ratio 2.5:1) SAINT-2/DOPE in 10µl 5% glucose, and after 20 minutes the lipoplexes were added on top of the mounted brain slice at 37°C. After 4 hrs, lipoplexes were removed and the medium was refreshed. The delivery efficiency was determined at 4 and 24 hr, and the transfection efficiency was analyzed after 2 and 6 days by (epi-)fluorescence microscopy (Olympus, Japan) or by TCS Leica SP2 confocal laser scanning microscopy (Wetzlar, Germany). The integrity of the plasma membranes of the cells in the brain slices was verified by Hoechst blue staining (20µg/ml, Molecular probe). The nuclei were counterstained with propidium iodide (2.5µg/ml) in the fixed brain slices. ODNs labeled with FITC, plasmids labeled with rhodamine, and SAINT-2/DOPE, traced with rhodamine-PE, were used to monitor their uptake by fluorescence microscopy.
Western blotting of the nucleic acid channel
The expression of the nucleic acid channel was examined by Western Immunoblot. Cerebella samples at P8 (8 days after birth) were prepared from fresh rat cerebellum, lysed in sample buffer (3ml/mg, 5%SDS, 5%mercaptoethanol, 8M urea, 6.25mM Tris-HCl, pH 6.8, and 0.01% bromophenol blue). 4, 9 and 15 µg of cerebellum samples were separated on 12.5% SDS-PAGE (Bio-Rad, Hercules, CA), blotted on a pure nitrocellulose membrane (Bio-Rad, Hercules, CA) and probed with rabbit GN-2640 (1:75). The blot was then probed with horseradish peroxidaseconjugated donkey anti-rabbit IgG (1:3000, Amersham Biosciences, Buckinghamshire, England), and processed using ECL (enhanced chemiluminescence) plus (Amersham Pharmacia Biotech) according to the manufacturer's instruction.
Inhibition of nucleic acid channel activity in brain slices.
Brain slices were prepared as above. The nucleic acid conducting channels in the brain slices were blocked either with specific polyclonal antibody, GN-2640, or with pre-immune serum at 4ºC for 2 hr at the indicated concentration. Alternatively, the channels were blocked with heparan sulfate or L-malic acid at a concentration range of 20 to 200µg/ml for 1 hr. Then one nmol ODNs, suspended in a volume of 50ul, were added to the brain slices, and after 30min the uptake of ODNs was analyzed by confocal microscopy.
Bolus injection of ODNs into rat brain in vivo.
A guide cannula was implanted into the right nucleus accumbens of Wistar rats. FITC-ODNs (0.1mM) diluted with 4.5% NaCl (4:1) was infused for 4 minutes into the nucleus accumbens (0.75µl/min) through a cannula after a brief anesthesia with isoflurane. After 4 or 24 hours the animals were decapitated, and the brain was dissected and frozen on dry ice. Subsequently, cyosections (20µm) were cut, collected and evaluated by fluorescence microscopy. Alternatively, the cannula was inserted into the lateral ventricle of adult Wistar rats under anesthesia. 5ug pGFP alone or complexed with 100nmol SAINT-2/DOPE in a volume of 15µl were bolus injected into ICV via a cannula (2 animals). GFP expression was examined after 48 h.
Results and Discussion
Uptake of ODNs by brain slices does not depend on cationic lipids
Free ODNs can be endocytosed by cultured cells and most of them end up in endocytic compartments. By contrast, when complexed with cationic lipids, the uptake of ODNs is not only enhanced but in this case translocation of ODNs from the endosomes into the cytosol occurs, which leads to nuclear uptake, a prerequisite for downregulation of protein targets. To verify our previous data on the cellular uptake of ODN lipoplexes and the functional down regulation of membrane receptors in neuronal cells in vitro, the next challenge was to investigate biological consequences of a similar approach in vivo. Therefore, we studied the uptake properties of ODNs by brain slices in the presence and absence of cationic lipids. In preliminary experiments, using freshly prepared brain slices, we observed a substantial internalization of FITC-labeled ODNs, even in the absence of SAINT-2/DOPE liposomes, and its diffuse distribution in cytosol and nucleus. Accordingly, taking our previous data obtained in cell cultures into account, these observations raised concern as to the integrity of the plasma membrane of the relevant cells. To exclude therefore that ODN uptake could be due to damage of the plasma membrane during slice preparation, the integrity of the membrane was verified by Hoechst staining. As shown in Fig.1A , when added to brain slices after their fixation with 3% paraformaldehyde, which is used as a positive control, Hoechst permeated into virtually every cell in the slice. When stained immediately after isolation, damage of the brain slices is particularly apparent at the periphery of the slices (Fig.1 B) . After 4 days of recovery in culture, the damage to the brain slices was essentially minimal and only occasional penetration of the Hoechst dye could be detected (Fig.1   C) . Therefore, all further experiments on the brain slices were carried out with preparations that had been cultured for four days. When such slices were treated with FITC-labeled ODNs and ODNs complexed with cationic lipids (SAINT-2/DOPE, 1:1) for 4 hr, qualitative analysis of the specimen by microscopy revealed that the uptake of ODNs per se (Fig.1 D) or ODNs complexed with cationic lipids (Fig.1 E) was almost identical. Furthermore, ODNs were taken up through the whole slice as readily determined by serial scanning by confocal microscopy (date not shown), while the uptake of ODNs continued to increase when monitored over a time interval of 24 hr (Fig.1 F) . Hence, these data not only imply that cationic lipids did not significantly improve the uptake of ODNs by the brain slices, but rather that ODNs were internalized by cells present in the slices without a need for a vector for internalization and, presumably, for their release from endocytic compartments. A priori, having demonstrated previously that endocytosed ODNs remain trapped within the endocytic compartments, these data could suggest that ODNs taken up by the cells in the brain slices did not substantially enter the cells by endocytosis. Rather direct access into the cytosol might have been acquired by direct translocation across the plasma membrane. Having thus acquired access to the cytosol, the ODNs will then readily accumulate in the nucleus via diffusion through the nuclear pore (12, 13) . It was therefore important to more carefully define the intracellular localization of internalized ODNs, incubated with the slices as such or when complexed with cationic lipids.
Free ODNs are internalized by brain cells and acquire access to the nucleus
As demonstrated in Fig. 2 , when FITC-ODNs alone ( Fig.2A, green) or complexed with cationic lipids (Fig.2 C) were applied to the brain slices, more than 50% of the cells showed high uptake of ODNs in the cytosol and/or nuclei. Accumulation of free ODNs in the nuclei (yellow) could be clearly discerned when the latter had been counterstained with propidium iodide (red) ( Fig.2A) . Occasionally, an almost exclusive localization in the cytosol was seen, while the ODNs
had not yet reached the nucleus (insert Fig. 2A) . Overall, the uptake of ODNs did not show a cell type-specific preference, as inferred from ODN internalization versus morphology of the cells in the brain slices. Fig. 1 Uptake of ODNs by brain slices. 400nm brain slices were prepared as described in Methods. To evaluate their plasma membrane integrity, the slices were incubated with the membrane permeating dye Hoechst (20µg/ml) at various conditions. A. The brain slice was fixed and permeabilized, and stained with Hoechst, the sample serving as a positive control. B. A brain slice was stained with Hoechst immediately after preparation C. A brain slice was kept in culture for four days and then stained with Hoechst. Note that after 4 days in culture only few plasma membrane damaged cells were apparent. D. Free FITC-ODNs (1 nmol) were incubated with the brain slice for 4 hr. E. FITC-ODNs (1 nmol), complexed with cationic lipids (75 nmol), were incubated with the brain slice for 4 hr. Note that visual inspection reveals that the uptake of free ODNs or ODNs complexed with cationic lipids is qualitatively very similar. F. Free FITC-ODNs (1 nmol) were incubated with brain slices for 24 hr and a gradual increase in uptake of ODNs was apparent.
When complexed with cationic lipids, efficient delivery of labeled ODNs into cells in the brain slices and their localization into cytosol and nucleus, were also readily observed (Fig.2C) .
N-Rh-PE-labeled cationic liposomes were rapidly taken up by the brain slices and they appeared as fine dots in intracellular compartments without showing any diffusion in the cytoplasm or nucleus (Fig. 2 B) . This would suggest that the cells most likely internalized the liposomes via an endocytic internalization mechanism, the particles becoming entrapped in endosmal/lysosomal compartments, consistent with previous observations (3, 14) . Note that FITC-labeled ODNs do escape from the complexes and reach the cytosol prior to reaching the nucleus, without the lipids reaching this organelle, since red fluorescence could not be detected in the nucleus (Fig. 2 B and   C) . Taken together, these data, in conjunction with those presented in Figure 1 The internalization of FITC-ODNs by brain slices was carried out at 4˚C (A) or 37 ˚C (B) as described in Methods for an incubation period of 2hr. Note that although it was less than at 37 ˚C (B), at 4˚C a prominent internalization of ODNs could be seen. The data imply that a mechanism other than endocytosis is involved in ODN internalization in brain slices.
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access to cells present in brain slices to very similar extents. Moreover, free ODNs do not become entrapped in the endocytotic pathway, but rather show a very similar distribution, i.e., in the cytosol and nucleus (Fig. 2) as that observed when delivered via cationic lipids. In relation to the notion that ODNs, present in endosomes do not substantially leak into the cytosol, the data strongly support the view that free ODNs, when incubated with brain slices must acquire cytosolic access by direct translocation across the plasma membrane, which is in marked contrast to an almost exclusive endocytic uptake of ODNs, when added to cells in culture. Accordingly, in order to translocate across the plasma membrane, a membrane localized transporter, present in cells that constitute the brain slices, would be a likely mechanism, given that permeation across perturbed plasma membranes can be excluded (see above). In fact, recently the presence of such nucleic acid channels has been demonstrated to be localized in the plasma membrane of rat kidney cells (15, 16) . The potential presence of such a channel in brain cells was therefore examined.
Entry of ODNs into cells in brain slices can be accomplished via nucleic acid channels
If direct uptake across the plasma membrane of brain cells would occur, and if endocytosis would not significantly contribute to ODN uptake, as characterized in the previous section, the effect of temperature might discriminate between either mechanism, endocytosis showing a prominent temperature dependence (17) (18) (19) . Interestingly, when brain slices were incubated with ODNs at 4°C for 2 hours, a substantial uptake could still be seen (Fig. 3 A) , although it was less than that at 37°C (Fig. 3 B) . Nevertheless, the experiment shows ODN uptake to occur at conditions, i.e., at 4 o C, where endocytosis is effectively inhibited, implying that entry into cells must take place via direct passage across the plasma membrane. Fig. 4 Expression of the nucleic acid channel in rat brain. The expression of the nucleic acid channel was examined with immuno-Western blot, as described in Methods. 4, 9 and 15 µg of the lysate of rat brain was separated and blotted on PAGE. One band at 83 kDa was detected, using the specific antibody GN-2640 in a dosedependent manner.
Further support for a non-endocytic pathway of entry of free ODN by brain slices was derived from inhibition experiments using heparan sulfate. This large polyanion is similar in molecular . Note that a strong inhibition of the uptake of ODNs could be seen in C and D, in which the nucleic acid channel had been pre-blocked with the channel specific antibody whereas the pre-immune serum (B) was without effect. E and F. The brain slices were pre-incubated with heparan sulfate before the addition of the same amount of FITC-ODNs. Note that the inhibitory effect of heparan sulfate was dose dependent, showing no effect at 20 ug/ml ( E ), while at 200 ug/ml, an inhibition of approx. 30 % was apparent (F ). G and H. The brain slices were treated with L-malate prior to the addition of ODNs (1 nmole). L-Malate acid (G. 20 ug/ml; H. 200ug/ml) did not interfere with the uptake of ODNs by the brain slices (compared to A).
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The nucleic acid channel is a heteromultimeric complex, which consists of at least two protein subunits, i.e., a 45-kDa pore forming subunit (p45) and a 36-kDa regulatory subunit (p36). The latter has been identified as a cytosolic malate dehydrogenase (cMDH), which seems to confer the selectivity of the pore protein to ODNs. Both phosphodiester and phosphothioate ODNs can be translocated via this channel (15) . To investigate the potential presence of this channel in brain cells, a cellular lysate of rat brain was prepared and the sample was analyzed by Western blotting, using an antibody, GN-2640, raised against a peptide of the 45-kDa pore-forming subunit, as detected in rat kidney. As shown in Fig. 4 , the antibody staining clearly revealed the presence of two protein bands in a dose-dependent manner, one showing a molecular weight of at 83kD. It is tempting to suggest that these bands presumably represent hetero-dimers of the putative ODN channel protein, which may thus bear a remarkable similarity with the heteromultimeric complex identified in rat kidney. To obtain further support for this notion, we next examined whether the channel's activity could be blocked upon binding of the antibody.
Interestingly, an antibody concentration dependent inhibition of the uptake of ODNs was observed ( Fig. 5 C, D) . As shown in Figure 5B , relative to control uptake of ODNs, no effect was seen when the brain slices had been preincubated with pre-immune serum. By contrast, an inhibition of ODN uptake by more than 50% occurred, as determined by fluorescence measurements in three independent experiments, when the slices had been preincubated with GN-2640 antibodies at 1:10 dilution (Fig. 5 C) . Hence, these data imply that a functionally active ODN translocator is present on brain cells, as localized in brain slices.
L-malate, which is a substrate for cytosolic malate dehydrogenase, has been identified as a regulatory subunit on the nucleic acid channel, and upon reconstitution of the channel in liposomes, L-malate was shown to block the reconstituted activity (16) . However, when Lmalate was preincubated with brain slices at concentrations ranging from 20 to 200µg/ml prior to addition of the ODNs, no significant effect on ODN uptake was apparent in this case (not shown). Hence, unlike an effective inhibition by the antibody raised against the pore-forming subunit no effect was seen when modulating the regulatory subunit of this channel with its substrate. However, the apparent discrepancy may be explained by taking into account that the L-malate-induced inhibition of the channel activity was reported for the liposomally reconstituted protein (16) . Not unlikely, at such conditions, at least part of the channels may be randomly reconstituted implying a partly exposure of the cMDH such that it may react with Lmalate, when the latter is added to the incubation medium. Using brain slices, like in our experiments, exogenously added L-malate will not readily gain access to cMDH, which may well be hidden in the channel complex, facing in vivo more likely the cytosolic site of the plasma membrane.
Plasmid uptake does not occur via ODN channels and requires cationic-lipid mediated delivery.
Since the data obtained thus far strongly suggest the presence of an ODN transfer channel in the plasma membrane of brain cells, as detected in brain slices, we next examined whether plasmids could also be translocated via the channel protein. Thus, rhodamine-labelled plasmids encoding GFP were incubated with brain slices, either at 4°C or 37°C. However, except for some fuzzy fluorescence at the cell's surface, no significant internalization of plasmid was apparent at either condition, as illustrated in Fig.6A for the interaction at 37°C. Consistent with this observation, neither was the expression of GFP fluorescence, acting as a reporter gene, apparent at either condition (Fig.6C ). This would imply that the nucleic acid channel is not adapted in carrying large size plasmids across the plasma membranes of brain cells. However, substantial internalization of rhodamine-labelled plasmids could be detected when complexed with cationic liposomes, and a subsequent incubation with the brain slices at 37°C (Fig. 6 B) . As a result, a relative high GFP expression was seen at the periphery of the slice, culminating in the transfection of approximately 100 cells per slice (Fig. 6 D) . Taken To determine whether ODN uptake in brain slices reflected an analogous mechanism by which ODNs could be taken up in vivo as well, FITC-ODNs were locally infused into the right nucleus accumbens in rats. After 4 hr, massive uptake of FITC-ODNs in cells localized near the point of injection was observed ( Fig. 7 A arrow) . Most interestingly, FITC-ODNs were not entrapped in vesicular compartments within the cell, but rather, showed a fairly diffuse appearance. This indicates that endocytosis is not the only mechanism for the uptake of ODNs in rat brain. This observation is consistent with the uptake of ODNs by the brain slices but contrasts with in vitro uptake by cell culture systems. Over a period of another 24 h, the number of cells that showed incorporation of ODNs further increased (Fig. 7 B) , although the region that became stained was largely restricted to that near the injection site, implying that further penetration of ODNs into the brain was rather poor. In contrast to the relatively rapid translocation of free ODNs into brain The uptake and transfection of pGFP in brain slices. Brain slices were treated with Rhodamine-labeled pGFP alone or when complexed with cationic lipids, prepared as described in the Methods. The transfection efficiency was examined 6 days after treatment. When pGFP alone was applied onto the brain slice, no significant uptake of rhodamine-labelled plasmid (red) could be observed (A) and no GFP transfection could be detected (C). When pGFP complexed with cationic lipids was applied, the uptake of rhodamine-labeled pGFP could be observed (B, red) and around 100 cells, localized near the periphery of the slice, expressed GFP (D, green).
Fig. 7
Infusion of ODNs or pGFP into rat brains in vivo. FITC-ODNs were infused into rat brains as described in Methods. The rat was sacrificed 4 or 24 hr after infusion, and brains were sectioned. The pictures were taken from areas that were near the infusion point. Note that after 4 hours (A) FITC-ODNs had prominently accumulated within the cells (arrow) and were also found in association with the extracellular space (arrow head). After 24 hr the pool of extracellular ODNs (arrow head, B) had decreased, while concomitantly an increase in cellular uptake of ODNs (arrow) was apparent. C. pGFP complexed with cationic lipids was infused into the brain of the rat as described in Methods. The GFP expression was examined after two days. Substantial expression, i.e., around 100 transfected cells, were seen directly adjacent to the injection site. No pGFP expression could be detected when pGFP alone was applied (data not shown).
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In this context it is interesting to note that in terms of efficiency cationic lipid mediated delivery of ODNs is nearly identical to the uptake of free ODNs in the brain slices. There are several possibilities that could account for the similarity in uptake at either condition. First, the entire complex of cationic lipid and ODNs is endocytosed, followed by the release of ODNs from endosomes and the nucleotide's accumulation in the nucleus (Fig.2C) , which has been well-documented for in vitro uptake by cell cultures (3, 21) . However, we also observed that cationic complexes were poorly penetrating, whereas ODNs were seen throughout the slice (Fig   1. E) . Accordingly, it is also possible that ODN complex/plasma membrane interaction may cause a destabilization of the complexes by charge neutralization and induce the release of
ODNs from the complexes. Dissociated ODNs may diffuse into the slice and subsequently enter the cells through the nucleic acid channel. The possibility of the latter scenario is suggested by observations that the cationic lipids were mostly seen at the surface or at the periphery of the slice ( Fig. 2 B, C) .
Evidently, these and other issues require further work. Yet, the unanticipated presence of nucleic acid channels on brain cells raises novel challenges and opportunities in the development of therapeutic strategies in the treatment of brain diseases. In this context, it will be of particular interest to develop devices that cross the blood brain barrier so that ODN-based approaches could rely on non-invasive protocols.
